Metropolitan Life Insurance Company (MetLife)’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,592
| Closed | -$1.45M | – | 2797 |
|
|
2021
Q4 | $1.45M | Sell |
15,592
-627
| -4% | -$41.3K | 0.02% | 704 |
|
|
2021
Q3 | $966K | Sell |
16,219
-604
| -4% | -$35.7K | 0.01% | 986 |
|
|
2021
Q2 | $1.15M | Buy |
16,823
+1,057
| +7% | +$68.9K | 0.02% | 904 |
|
|
2021
Q1 | $1.09M | Sell |
15,766
-765
| -5% | -$58.9K | 0.02% | 882 |
|
|
2020
Q4 | $1.27M | Sell |
16,531
-553
| -3% | -$41.5K | 0.02% | 733 |
|
|
2020
Q3 | $1.28M | Hold |
17,084
| – | – | 0.02% | 610 |
|
|
2020
Q2 | $1.08M | Buy |
17,084
+1,403
| +9% | +$77.2K | 0.02% | 694 |
|
|
2020
Q1 | $659K | Hold |
15,681
| – | – | 0.01% | 901 |
|
|
2019
Q4 | $712K | Sell |
15,681
-327
| -2% | -$15.5K | 0.01% | 1117 |
|
|
2019
Q3 | $733K | Buy |
16,008
+185
| +1% | +$10.4K | 0.01% | 1046 |
|
|
2019
Q2 | $928K | Hold |
15,823
| – | – | 0.02% | 937 |
|
|
2019
Q1 | $709K | Sell |
15,823
-333
| -2% | -$15.3K | 0.01% | 1088 |
|
|
2018
Q4 | $629K | Hold |
16,156
| – | – | 0.01% | 1069 |
|
|
2018
Q3 | $743K | Hold |
16,156
| – | – | 0.01% | 1092 |
|
|
2018
Q2 | $704K | Sell |
16,156
-12,011
| -43% | -$516K | 0.01% | 1102 |
|
|
2018
Q1 | $1.11M | Buy |
28,167
+15,355
| +120% | +$597K | 0.02% | 853 |
|
|
2017
Q4 | $435K | Sell |
12,812
-13,843
| -52% | -$394K | 0.01% | 1381 |
|
|
2017
Q3 | $680K | Buy |
26,655
+4,279
| +19% | +$98.1K | ﹤0.01% | 1484 |
|
|
2017
Q2 | $377K | Buy |
22,376
+5,159
| +30% | +$70.7K | ﹤0.01% | 1904 |
|
|
2017
Q1 | $251K | Buy |
17,217
+1,757
| +11% | +$26K | ﹤0.01% | 2122 |
|
|
2016
Q4 | $220K | Sell |
15,460
-168
| -1% | -$2.6K | ﹤0.01% | 2300 |
|
|
2016
Q3 | $273K | Sell |
15,628
-1,781
| -10% | -$29.5K | ﹤0.01% | 2131 |
|
|
2016
Q2 | $298K | Hold |
17,409
| – | – | ﹤0.01% | 2053 |
|
|
2016
Q1 | $343K | Buy |
17,409
+198
| +1% | +$3.17K | ﹤0.01% | 1814 |
|
|
2015
Q4 | $327K | Buy |
17,211
+139
| +0.8% | +$2.83K | ﹤0.01% | 1906 |
|
|
2015
Q3 | $326K | Buy |
17,072
+3,021
| +22% | +$103K | ﹤0.01% | 1929 |
|
|
2015
Q2 | $652K | Sell |
14,051
-3,885
| -22% | -$169K | ﹤0.01% | 1574 |
|
|
2015
Q1 | $784K | Buy |
17,936
+11
| +0.1% | +$511 | 0.01% | 1343 |
|
|
2014
Q4 | $622K | Hold |
17,925
| – | – | ﹤0.01% | 1615 |
|
|
2014
Q3 | $751K | Hold |
17,925
| – | – | 0.01% | 1458 |
|
|
2014
Q2 | $1.05M | Hold |
17,925
| – | – | 0.01% | 1317 |
|
|
2014
Q1 | $1.13M | Hold |
17,925
| – | – | 0.01% | 1264 |
|
|
2013
Q4 | $1.05M | Hold |
17,925
| – | – | 0.01% | 1293 |
|
|
2013
Q3 | $945K | Hold |
17,925
| – | – | 0.01% | 1316 |
|
|
2013
Q2 | $1.38M | Buy |
+17,925
| New | +$1.46M | 0.01% | 1078 |
|
Metropolitan Life Insurance Company (MetLife)'s ARNA Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 15,592 shares — an estimated $1.45M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $1.45M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 15,592 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.45M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Arena Pharmaceuticals Inc position peaked at $1.45M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.